FUNDED PROJECTS:
CHRONIC RESPIRATORY DISEASES

cartell MaratóIn 2003 the Marathon, which was dedicated to chronic respiratory diseases, received 105 project applications; these were evaluated by 52 scientific specialists around the world who drew up an order of priority depending on the methodological quality and relevance of the project. The assessment was managed by the Catalan Agency for Health Technology Assessment and Research
In accordance with the proposal from the Advisory Committee of the Fundació La Marató de TV3, the Board agreed to distribute, after paying the costs of the evaluation, € 3,344,269 to the 27 biomedical research projects listed below and used to support research on these diseases.
The results were published in the X Simposium Fundació La Marató de TV3which took place in 2009.

COPD: Effect of stop smoking on airway inflammation

  • Dr. Carlos Agustí García-Navarro
    Hospital Clínic i Provincial de Barcelona
Fund: 52.200 €

Phenotype characterisation and course of chronic obstructive pulmonary disease (COPD): PAC-COPD study

  • Dr. Josep M. Antó Boqué
    Institut Municipal d'Investigació Mèdica
Fund: 102.000 €

Understanding the molecular mechanisms responsible for skeletal muscle wasting in COPD patients: therapeutic implications

  • Dr. Josep Maria Argilés Huguet
    Facultat de Biologia. UB
Fund: 72.300 €

Study of genetic variants (SNP) involved in smoking cessation

  • Dr. Josep M. Argimón Pallàs
    DAP Costa de Ponent. Fundació Jordi Gol i Gurina
Fund: 179.563 €

Contribution of the vascular progenitor cells in the injury and vascular repair mechanisms in pulmonary circulation in chronic obstructive pulmonary disease

  • Dr. Joan Albert Barberà Mir
    Hospital Clínic i Provincial de Barcelona
Fund: 140.000 €

Clinical study of the significance of viral infection in the acute exacerbation of chronic obstructive pulmonary disease with emphasis on safe reduction of use of antibiotics

  • Dr. Josep Antón Capdevila Morell
    Hospital de Mataró
Fund: 100.860 €

Chronic respiratory disease and smoking in surgical patients in Catalonia: epidemiological profile, predictive factors of postoperative outcome and quality of life at three months

  • Dr. Jaume Canet Capeta
    Hospital Universitari Germans Trias i Pujol
Fund: 100.000 €

Non-invasive monitoring of respiratory patterns in COPD patients

  • Dr. Pere Casan Clara
    Hospital de la Santa Creu i Sant Pau
  • Dr. Pere Joan Riu Costa
    Centre de Recerca en Enginyeria Biomèdica. UPC
Fund: 101.750 €

Pathogenesis of COPD: the role of the bioactive sphingolipids in regulating apoptosis of the alveolar cells and screening of combinatorial lipid libraries for potential therapeutic use

  • Dra. Josefina Casas Brugulat
    Institut d'Investigacions Químiques i Ambientals de Barcelona
  • Dr. Antonio Delgado Cirilo
    Facultat de Farmàcia. UB
  • Dr. Antonio Gómez Muñoz
    Facultad de Ciencia y Tecnología. Universidad del País Vasco
Fund: 234.342 €

Tuberculosis in immigrants: an imported disease?

  • Dr. Joan Artur Caylà Buqueras
    Institut de Medicina i Salut. Agència de Salut Pública de Barcelona
Fund: 145.651 €

Local and systemic inflammation in patients with chronic obstructive pulmonary disease: determination of acute phase proteins and cytokines in infectious exacerbation

  • Dr. José Antonio Domínguez Benítez
    Hospital Universitari Germans Trias i Pujo
Fund: 150.000 €

Respiratory symptoms, asthma and passive smoking among schoolchildren: effectiveness of an integrated individual, family and school intervention

  • Dr. Esteve Fernández Muñoz
    Institut Català d'Oncologia
  • Dr. Manel Nebot Adell
    Institut de Medicina i Salut. Agència de Salut Pública de Barcelona
  • Dr. José A. Pascual Esteban
    Institut Municipal d'Investigació Mèdica
Fund: 283.790 €

Prevalence of osteoporosis in COPD males. Risk factors of osteoporosis and usefulness of densitometry in prediction of vertebral fractures

  • Dr. Jordi Gratacós Masmitjà
    Hospital de Sabadell
Fund: 109.062 €

New tools for the diagnosis and treatment of tuberculosis. Integrated immunological response against to lipidic and glycolipidic antigens of Mycobacterium tuberculosis

  • Dra. Esther Julián Gómez
    Facultat de Ciències. UAB
  • Dr. Carles Alonso Tarrés
    Hospital General de l'Hospitalet
Fund: 150.000 €

Environment, genes and asthma: an international study

  • Dr. Emmanouil Kogevinas
    Institut Municipal d'Investigació Mèdica
Fund: 119.088 €

Efficacy of respiratory rehabilitation in moderate COPD patients in primary health care and the maintenance of the benefits at two years

  • Dra. Concepción Larraz Gimeno
    Centre de Salut Escola Graduada. Institut Balear de Salut
Fund: 44.856 €

Colonisation of the airways of severe COPD patients by Aspergillus sp. A prevalence study and analysis of the associated factors

  • Dr. Frederic Manresa Presas
    Hospital Universitari de Bellvitge
Fund: 95.231 €

Infectious COPD exacerbations: risk factors for Pseudomonas aeruginosa isolation and influence of the virulence genes on outcome

  • Dra. Concepción Montón Soler
    Hospital de Sabadell
Fund: 150.000 €

Study of bronchial bacterial colonisation in COPD. Effect of antibiotic treatment in the eradication and prevention of exacerbations

  • Dr. Josep Morera Prat
    Hospital Universitari Germans Trias i Pujol
Fund: 137.640 €

Circulating endothelial progenitor cells in patients with obstructive sleep apnoea syndrome. Implications in cardiovascular risk

  • Dra. Mónica de la Peña Bravo
    Hospital Son Dureta. Palma de Mallorca
Fund: 16.740 €

Identification, synthesis and biological screening of new series drug leads with rational drug design approach for bradykine antagonism as an antiasthmatic therapeutic strategy

  • Dr. Juan Jesús Pérez González
    Escola Tècnica Superior d'Enginyeria Industrial. UPC
  • Dr. Josep Castells Boliart
    Institut Universitari de Ciència i Tecnologia. Mollet
Fund: 180.300 €

Inflammatory mechanisms and causes of Rapid-Onset Near-Fatal Asthma

  • Dr. Vicente Plaza Moral
    Hospital de la Santa Creu i Sant Pau
Fund: 46.350 €

Effects of reversible proteasome inhibitors on the mechanisms involved in inflammation and remodelling responses in asthma

  • Dra. Laura Pujols Tarrés
    Hospital Clínic i Provincial de Barcelona
  • Dr. Cristóbal Mezquita Pla
    Facultat de Medicina. UB
Fund: 100.000 €

Ventilator associated pneumonia COPD patients. Risk factors and clinical outcomes

  • Dr. Jordi Rello Condomines
    Hospital Universitari Joan XXIII
Fund: 150.000 €

Integrated care and biopathology of advanced COPD

  • Dr. Josep Roca Torrent
    Hospital Clínic i Provincial de Barcelona
Fund: 149.088 €

Lung structure and gas exchange in COPD undergoing lung transplantation

  • Dr. Robert Rodríguez Roisin
    Hospital Clínic i Provincial de Barcelona
  • Dr. Antonio Román Broto
    Hospital Universitari Vall d'Hebron
Fund: 109.500 €

Risk and pronostic factors of community acquired pneumonia in COPD patients. Impact of the inflammatory response

  • Dr. Antoni Torres Martí
    Hospital Clínic i Provincial de Barcelona
  • Dra. Rosario Menéndez Villanueva
    Hospital Universitari La Fe. València
Fund: 100.000 €
Anar al contingut